These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7872184)
1. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Ezekowitz MD; Hossack K; Mehta JL; Thadani U; Weidler DJ; Kostuk W; Awan N; Grossman W; Bommer W Am Heart J; 1995 Mar; 129(3):527-35. PubMed ID: 7872184 [TBL] [Abstract][Full Text] [Related]
2. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
3. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent. Kinnard DR; Harris M; Hossack KF J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930 [TBL] [Abstract][Full Text] [Related]
4. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852 [TBL] [Abstract][Full Text] [Related]
5. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276 [TBL] [Abstract][Full Text] [Related]
6. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study. DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085 [TBL] [Abstract][Full Text] [Related]
7. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy. Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710 [TBL] [Abstract][Full Text] [Related]
8. Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial. Koenig W; Höher M J Cardiovasc Pharmacol; 1997 Apr; 29(4):520-4. PubMed ID: 9156363 [TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Ruzyllo W; Tendera M; Ford I; Fox KM Drugs; 2007; 67(3):393-405. PubMed ID: 17335297 [TBL] [Abstract][Full Text] [Related]
10. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris. Glasser SP; West TW Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788 [TBL] [Abstract][Full Text] [Related]
11. Amlodipine and the total ischemic burden: circadian anti-ischemia program in Europe (CAPE) trial-methodology, safety and toleration. The Steering Committee members and all of the investigators. Detry JM Cardiology; 1994; 85 Suppl 2():24-30. PubMed ID: 7736484 [TBL] [Abstract][Full Text] [Related]
12. An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris. Bernink PJ; de Weerd P; ten CF; Remme WJ; Barth J; Enthoven R; Haagen FD; Holwerda NJ; Klomps HC J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S53-6. PubMed ID: 16296711 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris. Taylor SH; Lee P; Jackson N; Cocco G J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S46-9. PubMed ID: 16296709 [TBL] [Abstract][Full Text] [Related]
14. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance. Kinnard DR; Harris M; Hossack KF J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119 [TBL] [Abstract][Full Text] [Related]
15. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Thadani U; Ezekowitz M; Fenney L; Chiang YK Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941 [TBL] [Abstract][Full Text] [Related]
16. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L; J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985 [TBL] [Abstract][Full Text] [Related]
17. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo. Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191 [TBL] [Abstract][Full Text] [Related]
18. Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group. Deedwania PC Am J Cardiol; 1999 Apr; 83(7):1117-9, A8-9. PubMed ID: 10190530 [TBL] [Abstract][Full Text] [Related]
19. Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris. Klein G; Pfafferott C; Beil S; Gehring J; Niemelä M; Kendall MJ J Clin Pharm Ther; 1997; 22(5-6):371-8. PubMed ID: 19160722 [TBL] [Abstract][Full Text] [Related]
20. Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. The Investigators of Study 152. Singh S Clin Cardiol; 1993 Jan; 16(1):54-8. PubMed ID: 8416762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]